Jonathan B. Zuckerman

1.7k total citations · 1 hit paper
44 papers, 997 citations indexed

About

Jonathan B. Zuckerman is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Jonathan B. Zuckerman has authored 44 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Jonathan B. Zuckerman's work include Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (9 papers) and Tracheal and airway disorders (7 papers). Jonathan B. Zuckerman is often cited by papers focused on Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (9 papers) and Tracheal and airway disorders (7 papers). Jonathan B. Zuckerman collaborates with scholars based in United States, France and Germany. Jonathan B. Zuckerman's co-authors include Robert M. Kotloff, Thomas R. Kleyman, Steven Μ. Albelda, Rainer Wiewrodt, Peter R. Smith, Patrick A. Flume, Brett Charlton, Helge Hebestreit, Baofeng Hu and David E. Geller and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Jonathan B. Zuckerman

40 papers receiving 975 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

2023 82 citations Steven M. Rowe, Jonathan B. Zuckerman et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan B. Zuckerman United States	17	552	359	129	117	91	44	997
Vinciane Saint‐Criq France	17	555 1.0×	364 1.0×	64 0.5×	91 0.8×	51 0.6×	33	955
Elias Matouk Canada	16	637 1.2×	279 0.8×	50 0.4×	106 0.9×	68 0.7×	29	911
Ferenc Karpati Sweden	14	388 0.7×	182 0.5×	31 0.2×	85 0.7×	66 0.7×	26	672
G. Villegas United States	20	145 0.3×	539 1.5×	76 0.6×	98 0.8×	97 1.1×	34	1.3k
Hamza Aziz United States	9	257 0.5×	277 0.8×	198 1.5×	170 1.5×	170 1.9×	30	985
Víctor Toledano Spain	19	144 0.3×	331 0.9×	46 0.4×	231 2.0×	51 0.6×	29	1.1k
Antoine Soliman United States	10	341 0.6×	224 0.6×	123 1.0×	129 1.1×	212 2.3×	13	1.1k
Bérengère Villeret France	12	179 0.3×	316 0.9×	25 0.2×	88 0.8×	54 0.6×	17	836
Masafumi Hasui Japan	15	104 0.2×	123 0.3×	86 0.7×	106 0.9×	115 1.3×	46	721
A Rüdeberg Switzerland	10	623 1.1×	148 0.4×	30 0.2×	113 1.0×	48 0.5×	18	852

Countries citing papers authored by Jonathan B. Zuckerman

Since Specialization

Citations

This map shows the geographic impact of Jonathan B. Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan B. Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan B. Zuckerman more than expected).

Fields of papers citing papers by Jonathan B. Zuckerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan B. Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan B. Zuckerman. The network helps show where Jonathan B. Zuckerman may publish in the future.

Co-authorship network of co-authors of Jonathan B. Zuckerman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan B. Zuckerman. A scholar is included among the top collaborators of Jonathan B. Zuckerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan B. Zuckerman. Jonathan B. Zuckerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Konstan, Michael W., Deepika Polineni, James F. Chmiel, et al.. (2024). Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis. Journal of Cystic Fibrosis. 24(1). 83–90.

Jia, Shijing, Jonathan B. Zuckerman, Susan Murray, et al.. (2024). Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis. Journal of Cystic Fibrosis. 23(5). 878–884. 3 indexed citations

Zuckerman, Jonathan B., et al.. (2024). Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry. PLoS ONE. 19(12). e0313510–e0313510.

Rowe, Steven M., Jonathan B. Zuckerman, Daniel Dorgan, et al.. (2023). Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study. Journal of Cystic Fibrosis. 22(4). 656–664. 82 indexed citations breakdown →

Gifford, Alex H., Shijing Jia, Samya Z. Nasr, et al.. (2023). Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis. CHEST Journal. 164(3). 614–624. 3 indexed citations

López‐Pintado, Sara, et al.. (2023). Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry. Annals of the American Thoracic Society. 20(9). 1250–1257. 6 indexed citations

Gagnon, David J., Sergey Ryzhov, Meghan May, et al.. (2022). Ceftriaxone to PRevent pneumOnia and inflammaTion aftEr Cardiac arresT (PROTECT): study protocol for a randomized, placebo-controlled trial. Trials. 23(1). 197–197. 3 indexed citations

Craig, Wendy Y., et al.. (2021). Urinary stone disease prevalence and associations in cystic fibrosis. Urolithiasis. 49(5). 415–423. 7 indexed citations

May, Teresa, Alex H. Gifford, Thomas Lahiri, et al.. (2017). Complications of long and intermediate term venous catheters in cystic fibrosis patients: A multicenter study. Journal of Cystic Fibrosis. 17(1). 96–104. 16 indexed citations

10.

Flume, Patrick A., Moira L. Aitken, Diana Bilton, et al.. (2015). Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe. 11(1). 39–48. 19 indexed citations

11.

Gifford, Alex H., Zhigang Li, Lisa A. Moulton, et al.. (2013). Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis. Journal of Cystic Fibrosis. 13(3). 311–318. 25 indexed citations

12.

May, Teresa, et al.. (2013). Complications of Long and Intermediate Term Venous Catheters in CF Patients. CHEST Journal. 144(4). 755A–755A. 1 indexed citations

13.

Bilton, Diana, G. Bellon, Brett Charlton, et al.. (2012). Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. Journal of Cystic Fibrosis. 12(4). 367–376. 50 indexed citations

14.

Bilton, Diana, Moira L. Aitken, Patrick A. Flume, et al.. (2011). 78 Combined data from two phase III studies of Bronchitol (inhaled dry powder mannitol) in adult cystic fibrosis (CF) patients. Journal of Cystic Fibrosis. 10. S20–S20. 2 indexed citations

15.

Aitken, Moira L., G. Bellon, K. De Boeck, et al.. (2011). Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis: An International Randomized Study. American Journal of Respiratory and Critical Care Medicine. 185(6). 645–652. 94 indexed citations

16.

Zuckerman, Jonathan B., et al.. (2009). Bacterial contamination of cystic fibrosis clinics. Journal of Cystic Fibrosis. 8(3). 186–192. 28 indexed citations

17.

Zuckerman, Jonathan B. & David B. Seder. (2007). Infection Control Practice in Cystic Fibrosis Centers. Clinics in Chest Medicine. 28(2). 381–404. 8 indexed citations

18.

Zuckerman, Jonathan B., Cynthia B. Robinson, Richard Shell, et al.. (1999). A Phase I Study of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to a Lung Segment of Individuals with Cystic Fibrosis. Human Gene Therapy. 10(18). 2973–2985. 111 indexed citations

19.

Zuckerman, Jonathan B., Xiyin Chen, Joely D. Jacobs, et al.. (1999). Association of the Epithelial Sodium Channel with Apx and α-Spectrin in A6 Renal Epithelial Cells. Journal of Biological Chemistry. 274(33). 23286–23295. 62 indexed citations

20.

Zuckerman, Jonathan B. & Robert M. Kotloff. (1998). LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS. Clinics in Chest Medicine. 19(3). 535–554. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact